By Katlyn Mortimer Since the outbreak of COVID-19 forced many North Americans into a simulated depressive episode, prescriptions for antidepressant and anti-anxiety medication rose by 18.6 and 34.1 percent, respectively. These figures come from the United States, but Canada is